Delphi Ventures Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 5
Professionals
  • Investments
  • 305
  • Portfolio
  • 10
  • Exits
  • 184
Exits

Delphi Ventures General Information

Description

Founded in 1988, Delphi Ventures is a venture capital investment firm that prefers to invest in life sciences companies developing novel therapeutic drugs and innovative medical devices.

Contact Information

Year Founded
1988
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Venture Capital
Primary Office
  • 63 Bovet Road
  • Suite 351
  • San Mateo, CA 94402
  • United States
+1 (650) 000-0000

Delphi Ventures Investments & Acquisitions (305)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Pontem Network 03-Jun-2021 Seed Round 00.00 Financial Software Generating Revenue
000000000 18-May-2021 00000 00000 000 Financial Software Generating Revenue
00000 0000000 25-Mar-2021 0000 00000 Financial Software Startup
00000 24-Mar-2021 0000 00000 00.00 Financial Software Startup
0000(00000 0000000 02-Jan-2018 00000 00000 0000 Other Devices and Supplies Generating Revenue 00000 00000000
0000000 09-Jan-2017 00000 00000 0000 Surgical Devices Generating Revenue 0000000 000000
000 0000000 06-May-2015 00000 00000 000.00 Therapeutic Devices Generating Revenue 0000 0000000
0000(00000 0000000 04-May-2015 00000 00000 0000 Other Devices and Supplies Generating Revenue 00000 00000000
Ivantis 22-Sep-2014 Later Stage VC 000.00 Surgical Devices Generating Revenue 0000000 000000
Senseonics 01-Jun-2014 Later Stage VC 0000 Monitoring Equipment Generating Revenue/Not Profitable 0000000 000000
You’re viewing 10 of 305 investments and acquisitions. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Delphi Ventures Exits (184)

Company Name Exit Date Exit Type Exit Size
Cytel 17-Feb-2021 Buyout/LBO 000
0000(00000 0000000 02-Feb-2021 000000000000000000
0000000000 01-Feb-2021 000000000 00000000
00000000 01-Nov-2020 0000000000: 000000
00000 0000000 01-Dec-2019 000 00 00000000
0000000 0000000000 03-Sep-2019 000000000000000000 00000
0000000 0000000000 23-Apr-2019 000000000000000000 000.00
0000000 30-Jan-2019 000000000000000000
Astute Medical 04-Apr-2018 Merger/Acquisition 0000
Alder Biopharmaceuticals 31-Mar-2018 Secondary Transaction - Open Market
You’re viewing 10 of 184 exits. Get the full list »

Delphi Ventures Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Delphi Ventures‘s full profile, request access.

Request a free trial

Delphi Ventures Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Delphi Ventures Team (9)

Name Title Deals Funds Boards Office
Matthew Potter Chief Financial Officer & Partner San Mateo, CA
James Bochnowski Founder & Partner Emeritus 00 0 0 San Mateo, CA
David Douglass Partner Emeritus 00 0 San Mateo, CA
Olivia Liao Controller San Mateo, CA
Douglas Roeder Managing Member 00 0 0 San Mateo, CA
You’re viewing 5 of 9 team members. Get the full list »

Delphi Ventures Co-Investors (53)

Name With Exits Lead Partner Series Industry
Defiance Capital 2 Series chart Industry bar
Genblock Capital 0 Series chart Industry bar
Mechanism Capital 0 0 Series chart Industry bar
Morningstar Ventures 0 Series chart Industry bar
Ascension Ventures 0 0 Series chart Industry bar
You’re viewing 5 of 53 co-investors. Get the full list »